PATENT CLAIM ANALYSIS

Application Number: 15566852
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "025000"]

Abstract:
A composition for inhibiting a liver tumor in an organism is disclosed. The composition includes an activator being 1,2,3,4,6-penta-O-galloyl-Beta-D-glucopyranoside (PGG), wherein PGG is extracted from at least one of  Paeonia lactiflora  Pall. and Galla Chinesis.

Claim (Index 30):
The method as claimed in  claim 29 , wherein  Paeonia lactiflora  Pall. is selected as the medicament when a Z score corresponding to the GNMT promoter-driven luciferase reporter assay is greater than 1.5.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.17143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11832304', '14189685', '15753461', '13161817', '11575627']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.752412799049038
- 35 USC 102 Novelty (BERT): 0.5145322018331129
- Combined Prediction Score: 0.7286247393274455
- Mean Citation Score: 202.015392
- Max Citation Score: 229.50264
- Similarity Product: 129.13035007969378

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test